65 completed, 6 recruiting, 6 unknown, 2 active not recruiting. 83 Phase 1, 19 Phase 2.
Follow Streptococcal Infections: new trials by email Literature Review of Streptococcal Infections trials Research Report on Streptococcal Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-A1 in Healthy Young Adults Placebo, VAX-A1 Low, VAX-A1 Mid - Group A Streptococcal Infection | Phase 1 | Recruiting | Vaxcyte, Inc. | 80 | 2026-06-01 | 2026-06-16 |
| Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid) 24-valent pneumococcal polysaccharide conjugate vaccine (CRM197/tetanus toxoid) (referred to as PCV24) (dose M), PCV24 vaccine (dose H), PCV24 vaccine (dose M) - Streptococcus Pneumoniae Infection | Phase 1 / Phase 2 | Recruiting | CanSino Biologics Inc. | 854 | 2026-05-24 | 2026-08-05 |
| A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002) V118C (Stage 1), V118C (Stage 2), PCV20 (Stage 1) - Pneumococcal Infection | Phase 1 | Recruiting | Merck Sharp & Dohme LLC | 210 | 2026-01-13 | 2026-10-02 |
| Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor StrepIncor, Placebo - Rheumatic Heart Disease, Rheumatic Heart Disease in Children | Phase 1 / Phase 2 | Not yet recruiting | University of Sao Paulo General Hospital | 60 | 2025-10-01 | 2025-07-22 |
| Serum Collection Study for Assay Development Gamma-PN - Pneumococcal Disease, Invasive, Pneumococcal Disease | Phase 1 | Recruiting | GPN Vaccines | 12 | 2025-10-01 | 2025-10-03 |
| A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Aluminum Hydroxide (Alum) or AS37 in Healthy Young Adults Low dose Strep A Alum, Medium dose Strep A Alum, High dose Strep A Alum - Streptococcal Infections | Phase 1 | Recruiting | GlaxoSmithKline | 108 | 2025-07-29 | 2026-08-11 |
| A Study to Learn About How Safe and Effective is 20vPnC and 13vPnC Vaccines in Chinese Adults 20vPnC, 13vPnC - Pneumococcal Disease | Phase 1 | Completed | Pfizer | 400 | 2025-07-06 | 2026-02-25 |
| Clinical Trial of PCV24 in Adults Aged ≥18 Years Sinovac Low-dosage PCV24, Sinovac Middle-dosage PCV24, Sinovac High-dosage PCV24 - Pneumococcal Infectious Disease | Phase 1 / Phase 2 | Completed | Sinovac Life Sciences Co., Ltd. | 385 | 2025-06-18 | 2026-04-21 |
| A Study to Understand the Safety of the 20vPnC Vaccine in Healthy Chinese Adults, Children, and Infant 20vPnC, 13vPnC - Pneumococcal Disease | Phase 1 | Active not recruiting | Pfizer | 200 | 2025-06-15 | 2026-10-23 |
| A Phase I Clinical Study to Evaluate the Safety of PCV26 in Individuals ≥60 26-valent Pneumococcal Conjugate Vaccine, 13-valent Pneumococcal Conjugate Vaccine - Pneumococcal Diseases | Phase 1 | Not yet recruiting | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 60 | 2025-05-27 | 2025-05-18 |
| Clinical Trial of PCV24 in Infants Aged 2-23 Months Sinovac PCV24, Prevnar® - Pneumococcal Infectious Disease | Phase 1 | Recruiting | Sinovac Life Sciences Co., Ltd. | 180 | 2025-05-08 | 2026-01-28 |
| Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age. IVT GBS-06, Placebo - Group B Streptococcal Infections | Phase 1 / Phase 2 | Active not recruiting | Inventprise Inc. | 600 | 2024-11-12 | 2025-11-18 |
| Clinical Trial of PCV24 in Children Aged 2-17 Years Sinovac PCV24 formulation 1, Sinovac PCV24 formulation 2, Prevenar13® - Pneumococcal Infectious Disease | Phase 1 | Completed | Sinovac Life Sciences Co., Ltd. | 119 | 2024-09-07 | 2026-01-28 |
| Study of Gamma PN3 in the Elderly Gamma PN3, Prevnar - Pneumonia, Pneumococcal | Phase 1 | Completed | GPN Vaccines | 105 | 2024-08-26 | 2025-05-11 |
| Clinical Trial of PCV24 in Adults Sinovac PCV24 formulation 1, Sinovac PCV24 formulation 2, Pneumovax® - Pneumococcal Infectious Disease | Phase 1 | Completed | Sinovac Life Sciences Co., Ltd. | 170 | 2024-06-21 | 2025-04-16 |
| Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years PCV24 formulation 1, PCV24 formulation 2, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine - Pneumococcal Infectious Disease | Phase 1 | Completed | Reinovax Biologics Co., LTD | 230 | 2024-04-27 | 2026-08-17 |
| A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine Sinovac PCV13, PREVNAR 13 - Pneumococcal Infectious Disease | Phase 1 | Completed | Sinovac Research and Development Co., Ltd. | 140 | 2024-01-04 | 2026-01-28 |
| A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults Multivalent Pneumococcal Vaccine - Formulation 1, Multivalent Pneumococcal Vaccine - Formulation 2, 20-valent pneumococcal conjugate vaccine (20vPnC) - Pneumococcal Disease | Phase 1 / Phase 2 | Completed | Pfizer | 1710 | 2023-12-20 | 2026-11-06 |
| Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older Reinovax PCV24 formulation 1, Reinovax PCV24 formulation 2, PPSV23 - Pneumococcal Infectious Disease | Phase 1 | Completed | Reinovax Biologics Co., LTD | 240 | 2023-11-19 | 2024-11-07 |
| A Phase I Study of XJ103 in Chinese Healthy Subjects XJ103 Injection, Placebo - Pneumococcal Disease | Phase 1 | Unknown | Starmab biologics(Shanghai)Co,.ltd | 38 | 2023-09-12 | 2024-03-27 |
Showing 20 of 83. Sign in to see all of them.
Pneumococcal Infections (55) · Pneumonia, Pneumococcal (10) · Pneumonia (6) · Staphylococcal Skin Infections (4) · Pneumonia, Bacterial (3) · Rheumatic Fever (3) · Bacterial Infections (2) · Cellulitis (2) · HIV Infections (2) · Rheumatic Heart Disease (2) · AIDS-Related Complex (1) · Acquired Immunodeficiency Syndrome (1) · Dental Caries (1) · Gram-Positive Bacterial Infections (1)
Bacterial Infections and Mycoses (83) · Infections (83) · Gram-Positive Bacterial Infections (82) · Bacterial Infections (81) · Lung Diseases (17) · Respiratory Tract Diseases (17) · Respiratory Tract Infections (17) · Pneumonia (11) · Pneumonia, Bacterial (9) · Skin and Connective Tissue Diseases (8) · Pneumococcal Infections (6) · Connective Tissue Diseases (5) · Skin Diseases (5) · Skin Diseases, Bacterial (5)
13-valent pneumococcal vaccine (15) · Heptavalent Pneumococcal Conjugate Vaccine (9) · 23-valent pneumococcal capsular polysaccharide vaccine (8) · Pneumococcal Vaccines (8) · ceftobiprole (4) · PHiD-CV vaccine (2) · Sodium Chloride (2) · Tetanus Toxoid (2) · Vaccines, Combined (2) · 10-valent pneumococcal conjugate vaccine (1) · CRM197 (non-toxic variant of diphtheria toxin) (1) · Epinephrine (1) · Mupirocin (1) · Ointments (1) · Pentavac (1)
Pfizer (8) · GlaxoSmithKline (7) · Merck Sharp & Dohme LLC (7) · Sinovac Life Sciences Co., Ltd. (5) · Basilea Pharmaceutica (4) · GPN Vaccines (4) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (2) · CanSino Biologics Inc. (2) · Centers for Disease Control and Prevention (2) · Minervax ApS (2) · PATH (2) · Reinovax Biologics Co., LTD (2) · Sanofi (2) · Sanofi Pasteur, a Sanofi Company (2)
United States (18) · China (16) · Australia (8) · Belgium (5) · Germany (3) · South Korea (3) · Switzerland (3) · Bangladesh (2) · Brazil (2) · Canada (2) · Japan (2) · Kenya (2) · South Africa (2) · Sweden (2) · United Kingdom (2)
Geoff Kitson (2) · Kai Chu (2) · Myoung-don Oh, M.D. (2) · Andrew C Steer, MBBS,MPH,PhD (1) · Anthony Scott, MD, PhD (1) · Christopher Bailey, Bsc, PhD (1) · Du Lin, Master (1) · Ed Clarke, MD PhD (1)
PMID 30689507, PMID 10212363, PMID 1053919, PMID 10709851, PMID 10717828, PMID 10895619, PMID 11139785, PMID 11199555, PMID 11321382, PMID 11409642, PMID 1157366, PMID 1170757, PMID 11875603, PMID 12436828, PMID 12685620, PMID 12723166, PMID 12767443, PMID 12873775, PMID 13263433, PMID 14446037, PMID 1452871, PMID 14894244, PMID 15190533, PMID 15851928, PMID 15882530, PMID 15917682, PMID 16022946, PMID 16175029, PMID 16175030, PMID 16648419, PMID 16695846, PMID 17391816, PMID 1812051, PMID 18799552, PMID 19522655, PMID 1984216, PMID 20435707, PMID 2213464, PMID 22353593, PMID 2263330, PMID 23123106, PMID 23131206, PMID 23153437, PMID 23300160, PMID 23535358, PMID 2365491, PMID 23967126, PMID 24176494, PMID 24599529, PMID 24607003
2009 (1), 2015 (1), 2017 (1), 2019 (1)